Skip to content
OpenCapital
Get started

Select Medical Holdings SEM Merger consideration per share amount (in dollars per share)

Other financials

Income statement

See full
Revenue$1.4B+5.0%
Gross profit$175.5M-2.8%
Operating income$98.4M-12.7%
Net income$44.0M-22.4%
EPS (diluted)$0.35-20.5%

Balance sheet

See full
Cash & equivalents$25.7M-51.7%
Total debt$3.0B+7.5%
Total equity$1.8B+2.1%
Total assets$6.0B+6.1%

Cash flow

See full
Operating cash flow$37.9M+1,195%
CapEx$58.9M+12.5%
Free cash flow-$21.0M+62.3%

Valuation

See full
Market cap$2.05B-6.2%

Profitability

See full
Gross margin11.3%-0.5pp
Operating margin5.8%+0.8pp
Net margin2.4%-0.9pp
FCF margin2.8%-4.1pp

Returns & leverage

See full
Return on equity7.7%-3.6pp
Debt / equity1.7×+0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Select Medical Holdings in its filing.

Tagged under the XBRL concept sem:MergerAgreementMergerConsiderationPerShareAmount.

The official record: Select Medical Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Select Medical Holdings's merger consideration per share amount (in dollars per share)?
Select Medical Holdings (SEM) reported merger consideration per share amount (in dollars per share) of $16.50 in Q1 2026.